Jianzhijia Pharmaceutical Chain Group Balance Sheet Health
Financial Health criteria checks 3/6
Jianzhijia Pharmaceutical Chain Group has a total shareholder equity of CN¥2.7B and total debt of CN¥2.1B, which brings its debt-to-equity ratio to 79.1%. Its total assets and total liabilities are CN¥9.4B and CN¥6.7B respectively. Jianzhijia Pharmaceutical Chain Group's EBIT is CN¥689.9M making its interest coverage ratio 5.7. It has cash and short-term investments of CN¥836.9M.
Key information
79.1%
Debt to equity ratio
CN¥2.14b
Debt
| Interest coverage ratio | 5.7x |
| Cash | CN¥836.93m |
| Equity | CN¥2.71b |
| Total liabilities | CN¥6.71b |
| Total assets | CN¥9.42b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 605266's short term assets (CN¥3.7B) do not cover its short term liabilities (CN¥4.1B).
Long Term Liabilities: 605266's short term assets (CN¥3.7B) exceed its long term liabilities (CN¥2.6B).
Debt to Equity History and Analysis
Debt Level: 605266's net debt to equity ratio (48.2%) is considered high.
Reducing Debt: 605266's debt to equity ratio has increased from 25.4% to 79.1% over the past 5 years.
Debt Coverage: 605266's debt is well covered by operating cash flow (50.3%).
Interest Coverage: 605266's interest payments on its debt are well covered by EBIT (5.7x coverage).